Income Statement
BIOHAVEN LTD.
BHVN
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY |
|---|---|---|---|---|
|
Revenue
|
- | - | - | - |
|
Cost of Revenue
|
- | - | - | - |
|
Gross Profit
|
- | - | - | - |
|
Operating Expenses
|
745.38 | 885.11 | 436.05 | 567.93 |
|
Research & Development
|
635.07 | 795.87 | 373.28 | 437.07 |
|
Selling, General & Administrative
|
110.31 | 89.24 | 62.77 | 130.86 |
|
Other Operating Expenses
|
- | - | - | - |
|
Operating Income
|
-745.38 | -885.11 | -436.05 | -567.93 |
|
Non-Operating Income
|
8.00 | 39.42 | 26.50 | -1.91 |
|
Interest Income
|
14.72 | 21.51 | 17.92 | 3.24 |
|
Interest Expense
|
- | - | - | - |
|
Other Non-Op Income / Expense
|
8.00 | 39.42 | 0.00 | 0.00 |
|
Income Before Tax
|
-737.38 | -845.69 | -409.55 | -569.84 |
|
Income Tax Expense
|
1.44 | 0.74 | -1.38 | 0.44 |
|
Non-Controlling Interest
|
- | - | - | - |
|
Net Income
|
-738.82 | -846.42 | -408.17 | -570.28 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY |
|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - |
|
EBITDA
|
-735.46 | -877.26 | -429.14 | -566.55 |
|
Earnings Per Share (Basic)
|
-6.86 | -9.28 | -5.73 | -12.75 |
|
Diluted EPS
|
-6.86 | -9.28 | -5.73 | -12.75 |
|
Weighted Average Shares
|
107.62 | 91.23 | 71.20 | 44.74 |
|
Diluted Weighted Avg Shares
|
107.62 | 91.23 | 71.20 | 44.74 |
|
Comprehensive Income
|
-730.55 | -846.28 | -408.52 | -570.00 |